Cargando…
An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology
Immune-mediated diseases and immunotherapeutics can negatively affect normal immune functioning and, consequently, vaccine safety and response. The COVID-19 pandemic has incited research aimed at developing a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. As SARS-CoV-2 v...
Autores principales: | Gresham, Louise M., Marzario, Barbara, Dutz, Jan, Kirchhof, Mark G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816618/ https://www.ncbi.nlm.nih.gov/pubmed/33482251 http://dx.doi.org/10.1016/j.jaad.2021.01.047 |
Ejemplares similares
-
Response to comment on “An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.”
por: Gresham, Louise M., et al.
Publicado: (2021) -
Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
por: Speeckaert, Reinhart, et al.
Publicado: (2021) -
[Translated article] RF-SARS-CoV-2 Vaccination and Immunotherapy in Dermatology
por: Rodríguez-Villa Lario, A., et al.
Publicado: (2022) -
A case of drug-induced bullous pemphigoid secondary to immunotherapy
treated with upadacitinib: A case report
por: Gresham, Louise M, et al.
Publicado: (2023) -
Chilblain-like lesions coinciding with the SARS-CoV-2 pandemic
por: Starkey, Samantha Y., et al.
Publicado: (2022)